The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 16, 2014
Filed:
Feb. 24, 2011
Applicants:
Ashok Kumar Gangopadhyay, Mumbai, IN;
Kishorkumar Shivajirao Kadam, Mumbai, IN;
Ravindra Dnyandev Jadhav, Mumbai, IN;
Hitesh Mistry, Mumbai, IN;
Rajiv Sharma, Mumbai, IN;
Inventors:
Ashok Kumar Gangopadhyay, Mumbai, IN;
Kishorkumar Shivajirao Kadam, Mumbai, IN;
Ravindra Dnyandev Jadhav, Mumbai, IN;
Hitesh Mistry, Mumbai, IN;
Rajiv Sharma, Mumbai, IN;
Assignee:
Piramal Enterprises Limited, Mumbai, IN;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 261/14 (2006.01); C07D 417/12 (2006.01); C07D 417/14 (2006.01); C07D 277/56 (2006.01); A61K 31/422 (2006.01); A61K 31/427 (2006.01); C07D 271/06 (2006.01); C07D 413/12 (2006.01); C07D 413/14 (2006.01); A61K 31/42 (2006.01); A61K 31/4245 (2006.01); A61K 31/426 (2006.01); C07D 261/18 (2006.01); A61K 31/428 (2006.01); C07D 261/08 (2006.01); A61K 31/4439 (2006.01);
U.S. Cl.
CPC ...
C07D 417/12 (2013.01); C07D 277/56 (2013.01); A61K 31/422 (2013.01); A61K 31/427 (2013.01); C07D 271/06 (2013.01); C07D 413/12 (2013.01); C07D 413/14 (2013.01); A61K 31/42 (2013.01); A61K 31/4245 (2013.01); A61K 31/426 (2013.01); C07D 261/18 (2013.01); A61K 31/428 (2013.01); C07D 261/08 (2013.01); A61K 31/4439 (2013.01);
Abstract
The present invention relates to isoxazole, thiazole and oxidiazole derivatives, processes for their preparation, pharmaceutical compositions containing them and their use as medicaments, in particular to the use of these compounds in the prevention and treatment of diseases or disorders mediated by diacylglycerol acyltransferase (DGAT), particularly DGAT1.